Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials

Journal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.21-21, Article 21 [Peer Reviewed Journal]

The Author(s) 2024 ;2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05530-3 ;PMID: 38244085

Digital Resources/Online E-Resources